SCIENCE: An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels.
Speech sensitive to treatment response
J Neurol. 2015 May;262(5):1344-53. doi: 10.1007/s00415-015-7719-2
Speech sensitive to treatment response
J Neurol. 2015 May;262(5):1344-53. doi: 10.1007/s00415-015-7719-2